NasdaqGS - Nasdaq Real Time Price USD

LifeStance Health Group, Inc. (LFST)

5.73
-0.08
(-1.38%)
At close: May 9 at 4:00:00 PM EDT
5.73
0.00
(0.00%)
After hours: May 9 at 4:26:15 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,283,503
1,250,970
1,055,665
859,542
667,511
Cost of Revenue
866,039
848,571
753,569
622,525
466,003
Gross Profit
417,464
402,399
302,096
237,017
201,508
Operating Expense
430,701
434,012
491,230
447,191
487,861
Operating Income
-13,237
-31,613
-189,134
-210,174
-286,353
Net Non Operating Interest Income Expense
-23,705
-26,535
-21,220
-19,928
-38,911
Other Income Expense
-1,407
535
3,771
-2,628
-7,841
Pretax Income
-38,349
-57,613
-206,583
-232,730
-333,105
Tax Provision
-2,712
-170
-20,321
-17,166
-25,908
Net Income Common Stockholders
-35,637
-57,443
-186,262
-215,564
-343,947
Diluted NI Available to Com Stockholders
-35,637
-57,443
-186,262
-215,564
-343,947
Basic EPS
-0.09
-0.15
-0.51
-0.61
-1.05
Diluted EPS
-0.09
-0.15
-0.51
-0.61
-1.05
Basic Average Shares
380,882.25
379,147
367,457
355,278
327,523
Diluted Average Shares
380,882.25
379,147
367,457
355,278
327,523
Total Operating Income as Reported
-13,237
-31,613
-189,134
-210,174
-286,353
Total Expenses
1,296,740
1,282,583
1,244,799
1,069,716
953,864
Net Income from Continuing & Discontinued Operation
-35,637
-57,443
-186,262
-215,564
-307,197
Normalized Income
-34,598.99
-58,338.31
-189,764.47
-213,332.34
-301,322.02
Interest Expense
23,705
26,535
21,220
19,928
38,911
Net Interest Income
-23,705
-26,535
-21,220
-19,928
-38,911
EBIT
-14,644
-31,078
-185,363
-212,802
-294,194
EBITDA
47,498
39,872
-104,926
-143,604
-240,058
Reconciled Cost of Revenue
866,039
848,571
753,569
622,525
466,003
Reconciled Depreciation
62,142
70,950
80,437
69,198
54,136
Net Income from Continuing Operation Net Minority Interest
-35,637
-57,443
-186,262
-215,564
-307,197
Total Unusual Items Excluding Goodwill
-1,117
898
3,883
-2,410
-6,372
Total Unusual Items
-1,117
898
3,883
-2,410
-6,372
Normalized EBITDA
48,615
38,974
-108,809
-141,194
-233,686
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-78.99
2.69
380.53
-178.34
-497.02
12/31/2021 - 6/10/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers